Navigation Links
Johnson & Johnson Receives Approval from European Commission
Date:1/28/2011

results could vary materially from Johnson & Johnson's and Crucell's expectations and projections. Risks and uncertainties include the fact that the transaction is conditioned on the successful tender of the outstanding ordinary shares of Crucell, the receipt of required government and regulatory approvals and certain other customary closing conditions; general industry conditions and competition; general domestic and international economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations affecting domestic and foreign operations; and trends toward health care cost containment. In addition, if and when the transaction is consummated, there will be risks and uncertainties related to Johnson & Johnson's ability to successfully integrate the products and employees of Johnson & Johnson and Crucell as well as the ability to ensure continued performance or market growth of Crucell's products. A further list and description of these risks, uncertainties and other factors and the general risks associated with the respective businesses of Johnson & Johnson and Crucell can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended January 3, 2010, and Crucell's Annual Report/ Form 20-F for the fiscal year ended December 31, 2009, as filed with the U.S. Securities and Exchange Commission on April 7, 2010, as well as other subsequent filings. Crucell prepares its financial statements under International Financial Reporting Standards (IFRS). Copies of these filings are available online at www.sec.gov, www.jnj.com, www.crucell.com or on request from Johnson & Jo
'/>"/>
SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer
2. Johnson & Johnson Reports 2010 Fourth-Quarter and Full-Year Results
3. Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan
4. Reportlinker Adds Johnson & Johnson: PharmaVitae Profile
5. Boston Scientific Announces Election of Dr. Kristina M. Johnson to its Board of Directors
6. Johnson & Johnson Announces Executive Appointments: Alex Gorsky, Vice Chairman, Executive Committee Sheri McCoy, Vice Chairman, Executive Committee
7. Johnson & Johnson and Crucell Provide Progress Update on Preparations for Public Offer
8. Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Pharmaceutical Business
9. Two-Time Super Bowl Champion Coach & Sports Broadcaster Jimmy Johnson Laughs About His Notoriety in New ExtenZe Spots from Inter/Media Advertising
10. Surveyed European Oncologists Assign Greater Patient Share to Johnson & Johnsons Abiraterone Compared With Other Emerging Therapies in Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
11. Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015 The Medical ... featured in the American Medical Group Association,s "High ... AMGA,s "High Performing Health" production is ... facing the nation,s healthcare system in delivering better ... profiled along with other leading organizations in the ...
(Date:3/31/2015)... March 31, 2015 According ... and Chemical Instrumentation Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, ... Incubator, Fume Hood, Centrifuge) - Global Forecast to ... and Chemical Instrumentation Market is expected to reach ... from 2014 to 2019. Browse ...
(Date:3/31/2015)... March 31, 2015 Ryan & Maniskas, ... of directors of Hyperion Therapeutics, Inc. ("Hyperion" or the ... fiduciary duty and other violations of law related to ... Pharma plc in a transaction valued at approximately $1.1 ... and would like to learn more about this class ...
Breaking Medicine Technology:AMGA's High Performing Health News Program Features The Medical Letter 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 5Ryan & Maniskas, LLP Announces Investigation of Hyperion Therapeutics, Inc. 2
... patients with acute coronary syndrome being managed with ... ... TOKYO and INDIANAPOLIS, Feb. 21 Daiichi,Sankyo Company, Limited (TSE: 4568) ... the U.S. Food and Drug Administration (FDA) accepted,and designated Priority Review ...
... 21 MonoSol Rx, a drug delivery,company specializing ... it has successfully completed a pilot clinical study ... 5-HT3 receptor antagonist,used in the prevention and treatment ... film formulation of ondansetron was studied against,GlaxoSmithKline,s Zofran ...
Cached Medicine Technology:FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel 2FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel 3MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study 2MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study 3
(Date:3/31/2015)... (PRWEB) March 31, 2015 Williams ... a repair visit when their home comfort is ... and make the visit fit into the customer’s ... provide fast, quality repair at requested times. ... and commercial customers in the Indianapolis area can ...
(Date:3/31/2015)... 2015 Tickets are now on sale ... tradition since 1973. The 2015 Spring production, Fairy Tales ... Ice. On April 24 in partnership with the Alzheimer's ... night tribute to the Pat Bowlen family, long-time partners ... the opening event proceeds will go to the Alzheimer's ...
(Date:3/31/2015)... Fitbody Personal Training LLC invites participants to get ready for ... workouts away from the gym and prepare to energize the ... LLC. The classes are moving outdoors. , Personal trainer ... outdoors on Thursday evenings starting April 2, 2015 and ending ... starts on April 11th and ends on May 16, 2015. ...
(Date:3/31/2015)... QMedET Solutions, LLC, is now ... industry’s most advanced speech recognition technology to another ... now experience the full benefits of a speech-enabled ... support services that ensure successful integration with leading ... proud to provide Dragon Medical Practice Edition 2 ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 The Oliver ... page in response to client requests after Zofran ... that Zofran manufacturer, GlaxoSmithKline (GSK) failed to warn physicians ... associated with the medication and “illegally and fraudently” promoted ... women without receiving approval for that use from the ...
Breaking Medicine News(10 mins):Health News:Williams Comfort Air Launches Online Scheduling Tool to Indianapolis-Area Home and Business Owners 2Health News:FitBody Personal Training LLC Announces its Personal Training Classes are Moving Outdoors 2Health News:QMedET Solutions Announces Addition of Dragon® Medical Practice Edition 2 to its Roster of Products 2Health News:Zofran Lawsuit Information Page Launched In Response To Clients Request For Information On Potential For Zofran Birth Defects, The Olive Law Group 2Health News:Zofran Lawsuit Information Page Launched In Response To Clients Request For Information On Potential For Zofran Birth Defects, The Olive Law Group 3
... According to researchers at Hopkins University, they have found a ... in the immune system, surpassing an obstacle to certain ... from improving the body's immune response to developing cancer vaccines ... cells form the core of the blood system.// They can ...
... micro capsule coated with silicon, which could save the ... absorbing nutrients from the body //and stimulates the ... than onece a day to maintain their blood sugar ... Desai of the University of Illinois at Chicago Ms ...
... leading cause of disability in the United States, affects ... advances in treatment options and educational efforts,// depression has ... US. In fact, a recent study stressed that as ... fail to receive adequate treatment. ,Americans have ...
... the greatest increase in bone mineral after the growth spurt ... are in danger of suffering broken bones in later life,// ... skeleton during a vital two-year window before puberty, which is ... be between 10 and 12 and in boys it is ...
... electromagnetic fields (EMF) at home could double the risk ... //The three-year review was carried out for the International ... epidemiologists from major institutions around the world. ,Leukemia, ... third of all childhood cancers - around the world ...
... common learning disorder, affects nearly one in 24 people. ... read, write and spell. Dyslexia was found to have ... of the brain that controls movement, co-ordination and balance, ... led by Professor Roderick Nicolson, compared the brain activity ...
Cached Medicine News:Health News:A new study surpasses Gene Therapy Hurdle 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: